Company profile for PolyProx Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

PolyProx Therapeutics is developing biopharmaceuticals, called Polyproxin™ molecules, that target and remove disease-causing proteins using the natural degradation machineries contained within the cell. Our initial focus is in developing Polyproxin™ drug candidates for use in the treatment of cancers, targeting aberrant proteins that have previously proven difficult to target using conventional drug classes, such as sma...
PolyProx Therapeutics is developing biopharmaceuticals, called Polyproxin™ molecules, that target and remove disease-causing proteins using the natural degradation machineries contained within the cell. Our initial focus is in developing Polyproxin™ drug candidates for use in the treatment of cancers, targeting aberrant proteins that have previously proven difficult to target using conventional drug classes, such as small molecules or monoclonal antibodies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Jonas Webb Building (B910), Babraham Research Campus, Cambridge CB22 3AT
Telephone
Telephone
+44 (0)1223 628700
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty